Posted inComunicati
New indication in children from birth for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE VILLEPINTE, France, Jan. 27, 2026 /PRNewswire/ -- Guerbet (FR0000032526 GBT),…









